Qube Research & Technologies Ltd
- SEC CIK
- 0001729829
- Latest filing
- Aug 14, 2026
LFCR holding history
Lifecore Biomedical, Inc. in every 13F filed by Qube Research & Technologies Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
LFCR overviewAll 13F holders of LFCRFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 11
- Since Q2 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −75,097−100.0% | Sold out | Holders |
| Q1 2026 | 75,097 | $279.4K | <0.1% | +75,097 | New | Holders |
| Q4 2025 | 0 | $0 | 0.0% | −14,133−100.0% | Sold out | Holders |
| Q3 2025 | 14,133 | $104.0K | <0.1% | −3,533−20.0% | Reduced | Holders |
| Q2 2025 | 17,666 | $143.4K | <0.1% | −37,741−68.1% | Reduced | Holders |
| Q1 2025 | 55,407 | $390.1K | <0.1% | −19,325−25.9% | Reduced | Holders |
| Q4 2024 | 74,732 | $555.3K | <0.1% | −19,644−20.8% | Reduced | Holders |
| Q3 2024 | 94,376 | $465.3K | <0.1% | +12,904+15.8% | Added | Holders |
| Q2 2024 | 81,472 | $418.0K | <0.1% | −61,807−43.1% | Reduced | Holders |
| Q1 2024 | 143,279 | $760.8K | <0.1% | −4,147−2.8% | Reduced | Holders |
| Q4 2023 | 147,426 | $912.6K | <0.1% | +120,095+439.4% | Added | Holders |
| Q3 2023 | 27,331 | $206.2K | <0.1% | −580−2.1% | Reduced | Holders |
| Q2 2023 | 27,911 | $269.9K | <0.1% | +27,911 | New | Holders |